The absence of glucagon-mediated metabolic activation means less thermogenic effect and potentially fewer early sleep disruptions
Smaller, more frequent meals may be easier to manage than three large ones
Other recognised side effects include: Injection site reactions (redness, itching, bruising) Decreased appetite Gallbladder disease (cholelithiasis, cholecystitis) Rare but serious adverse effects that require immediate medical attention include: Pancreatitis (severe, persistent abdominal pain) semaglutide should be discontinued if pancreatitis is suspected Diabetic retinopathy complications (in patients with pre-existing retinopathy) Acute kidney injury (particularly in the context of severe dehydration) Severe allergic reactions (anaphylaxis, angioedema) Patients should be counselled about these potential effects before starting treatment and provided with clear guidance on recognising symptoms that warrant urgent medical review
Nausea, tiny appetite, wasted food meals that used to comfort me suddenly felt overwhelming
Monitor all VYVANSE-treated patients for potential tachycardia and hypertension
Histochemical evaluation of glutathione in brain